Cellular entry machinery

Cellular entry machinery refers to the collective set of host cell surface proteins, including receptors, co-receptors, and proteases, that pathogens exploit to gain access to the intracellular environment [1, 9]. In the context of viral infections, this machinery typically involves a primary binding receptor (such as ACE2 for SARS-CoV-2 or CD4 for HIV) and often requires secondary factors like co-receptors (CCR5/CXCR4) or activating proteases (TMPRSS2, Cathepsins) to facilitate membrane fusion or endocytosis [3, 4, 8]. Because these host factors are essential for the initiation of the viral life cycle, they represent critical therapeutic targets for the development of entry inhibitors [1, 3]. Drugs targeting this machinery aim to block the initial interaction between the pathogen's surface proteins and the host cell, thereby preventing infection and reducing viral load [1, 4]. For example, the inhibition of TMPRSS2 by drugs like camostat mesylate prevents the proteolytic priming of the viral spike protein, which is a prerequisite for fusion with the host membrane [3, 9]. Similarly, CCR5 antagonists like maraviroc block the co-receptor binding site, effectively halting HIV-1 entry into immune cells [4]. However, targeting host proteins requires careful consideration of their endogenous physiological roles, such as the regulation of blood pressure and inflammation by ACE2, to avoid adverse therapeutic effects [1, 9].

Other names

Host entry factorsViral entry machineryPathogen entry machineryCell entry mediators

Inhibition of viral attachment to host receptors, blockade of co-receptor binding, or proteolytic inhibition of viral fusion proteins.